Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
- PMID: 10617300
- DOI: 10.1023/a:1006273516976
Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype
Abstract
Loss of heterozygosity (LOH) in loci of the 10q23 region that harbor the PTEN gene and mutations in the sequence of this gene have been found in several primary human tumors including breast carcinomas, suggesting that this gene could be implicated in their pathogenesis. We investigated allelic losses in microsatellites of the 10q23 region, and their correlations with nine pathologic parameters in 105 breast carcinomas. The LOH analysis was performed by amplifying DNA by PCR, using five markers of the 10q23 region (D10S1687, D10S541, D10S2491, D10S583 and D10S571). LOH in at least one marker of the PTEN region was found in 29.5% of tumors. The statistical comparison between carcinomas with and without LOH in terms of the pathologic parameters showed significant differences in age (p = 0.03), lymph node metastases (p = 0.02), and higher histological grade (p = 0.02); a trend toward significance was found for progesterone receptors (p = 0.05). LOH in an individual marker and statistically significant relationships to tumor characteristics were observed at locus D10S541 for lymph node metastases (p = 0.04), at D10S2491 (intragenic to the PTEN gene) for lymph node metastases (p = 0.02), and at D10S583 for progesterone receptors (p = 0.01) and for high grade (p = 0.03). These results suggest the PTEN gene, or other genes of the 10q23 region, could be functionally related to breast cancer, probably influencing the development of histological features associated with poor prognosis.
Similar articles
-
Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.Breast Cancer Res Treat. 1999 Jan;53(1):9-17. doi: 10.1023/a:1006082117266. Breast Cancer Res Treat. 1999. PMID: 10206068
-
[Altered expression of PTEN gene and LOH of its epigenetic microsatellite in gastric carcinoma].Zhonghua Zhong Liu Za Zhi. 2004 Jul;26(7):389-92. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15355640 Chinese.
-
Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.Cancer Lett. 2004 Jul 16;210(2):239-44. doi: 10.1016/j.canlet.2004.01.018. Cancer Lett. 2004. PMID: 15183540
-
Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.Br J Cancer. 1999 Feb;79(5-6):718-23. doi: 10.1038/sj.bjc.6690115. Br J Cancer. 1999. PMID: 10070859 Free PMC article.
-
Allelic loss in breast cancer.Cancer Detect Prev. 2002;26(6):426-34. doi: 10.1016/s0361-090x(02)00128-9. Cancer Detect Prev. 2002. PMID: 12507227 Review.
Cited by
-
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.Cancer Res. 2009 Nov 1;69(21):8275-83. doi: 10.1158/0008-5472.CAN-09-1067. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843859 Free PMC article.
-
PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.J Biol Chem. 2009 Jul 10;284(28):19018-26. doi: 10.1074/jbc.M109.018937. Epub 2009 May 12. J Biol Chem. 2009. PMID: 19435886 Free PMC article.
-
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.Signal Transduct Target Ther. 2024 Apr 3;9(1):83. doi: 10.1038/s41392-024-01779-3. Signal Transduct Target Ther. 2024. PMID: 38570490 Free PMC article. Review.
-
Inhibition of phosphoinositide 3-kinase enhances the cytotoxicity of AG1478, an epidermal growth factor receptor inhibitor, in breast cancer cells.Med Oncol. 2012 Dec;29(5):3258-64. doi: 10.1007/s12032-012-0279-8. Epub 2012 Jun 23. Med Oncol. 2012. PMID: 22729368
-
PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.Br J Cancer. 2006 Jan 30;94(2):247-52. doi: 10.1038/sj.bjc.6602926. Br J Cancer. 2006. PMID: 16404430 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials